MRC Technology has entered into a strategic collaboration with EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) to identify novel drug targets in the field of small molecules and antibodies. The companies will work together to fast track targets through drug discovery with the goal of creating potent and selective novel therapeutics. The agreement combines EMBLEM’s experience in supporting academics with MRC’s expertise in translating novel biology targets into lead stage therapeutic...